Background: Women with diabetes experience an increased risk of adverse pregnancy outcomes. Aim: We aim to describe and quantify the psychological impact of the diagnosis of diabetes in pregnant women with type 1 diabetes and gestational diabetes mellitus (GDM) compared to each other and to their counterparts without diabetes. Design: This is a survey-based study with prospective collection of pregnancy outcome data. Methods: A total of 218 pregnant women (50% with diabetes) were administered questionnaires relating to psychological health. Maternal and neonatal characteristics and pregnancy outcomes were collected. Associations between key psychometric and health outcome variables were examined. Results: At least 25% of women in all three pregnancy groups had scores indicating affective distress in at least one domain. Compared to those with type 1 diabetes, women with GDM evidenced a greater number of uplifts in pregnancy (U ¼ 94, P ¼ 0.041), but also higher levels of overall anxiety (U ¼ 92, P ¼ 0.03) and stress (U ¼ 82, P < 0.01). Women with GDM also had significantly elevated overall depression scores, compared with the control group (U ¼ 34, P ¼ 0.02). Both groups of women with diabetes had clinically elevated levels of diabetes-related distress. There were no associations between maternal psychological variables and pregnancy outcomes. Conclusions: This work highlights a potential role for targeted psychological interventions to address and relieve symptoms of anxiety and depression among pregnant women with diabetes.
Introduction
Despite advances in clinical care, women with diabetes in pregnancy remain at increased risk of adverse outcomes. Pregestational diabetes mellitus (PGDM), including type 1 and type 2 diabetes, is associated with a congenital malformation rate twice that of the background population, a 5-fold increased risk of stillbirth and a 3-fold increased risk of perinatal mortality. 1, 2 PGDM currently affects 0.6% of pregnancies, but the increasing prevalence of type 2 diabetes in pregnancy correlating with the concurrent rise in obesity and metabolic syndrome will lead to an increase in those affected. 3, 4 Gestational diabetes mellitus (GDM) is diabetes diagnosed in the second or third trimester of pregnancy that is not clearly overt diabetes. 5 This condition affects up to 12.4% of pregnancies and is associated with a 30% increased risk of caesarean delivery and a 50% increased risk of gestational hypertension. Their offspring are 3.5 times more likely to develop neonatal hypoglycaemia and women with prior GDM experience an increased risk of persistent dysglycaemia and type 2 diabetes in later life. 6, 7 Pregnant women may experience fluctuating levels of stress throughout the pregnancy and mood disorders including depression are commonly described. [8] [9] [10] Using self-report questionnaires (Prenatal Psychosocial Profile Stress Scale), Woods et al. evaluated 1522 women and found that the majority reported antenatal psychosocial stress (78% low/moderate and 6% high). 8 While the pathophysiological mechanism of stress and depression in pregnancy is not clear, Kamysheva et al. described an association between more frequent and intense physical symptoms and depressive symptoms during pregnancy as measured using the Beck Depression Inventory. 10 Diabetes in pregnancy is associated with the need for intensive selfmanagement with regular capillary blood glucose monitoring, diet and lifestyle changes and frequently insulin injections or other pharmacological therapy. 4 It is therefore logical to assume that the diagnosis of diabetes may cause additional stress over and above the usual challenges of pregnancy. Furthermore, women with PGDM are potentially at highest risk as they are typically diagnosed prenatally and must manage the condition throughout all trimesters of pregnancy. This hypothesis is supported by findings outside of pregnancy demonstrating that the prevalence of depression is higher among women with diabetes than in the background population.
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Prior work involving selected groups of pregnant women with GDM suggests that they do experience higher stress levels than healthy pregnant women. [12] [13] [14] Hayase et al. evaluated 56
women diagnosed with pregnancy-induced hypertension or GDM using the Perceived Stress Scale questionnaire and found that these women experience higher stress levels than nonpregnant or healthy pregnant women. 13 In a pilot study using self-report questionnaires, Lydon et al. compared 25 women with GDM to 25 pregnant women without diabetes. They reported significantly higher scores on the depression subscale of the Depression Anxiety Stress Scale (DASS) among women with GDM. 14 Furthermore, in women with GDM, a history of depression and specific patterns of stress during early and midpregnancy may influence the risk of glucose intolerance in later pregnancy. 15, 16 These latter findings support the theory of a bidirectional relationship between mood disorders and diabetes in pregnancy. Despite this previous research, relatively little is known about the levels of psychological stress and depression in women with PGDM and GDM compared to each other and to women without diabetes in pregnancy. This information could facilitate the provision of targeted psychological interventions pre-pregnancy and in early pregnancy to ameliorate distress. These interventions are of potential importance as there is evidence that in women with PGDM, the presence of depressive symptoms in early pregnancy is associated with the adverse outcome of preterm delivery. 17 In this study, we aim to describe and quantify the psychological impact of having diabetes in women with PGDM and GDM compared to each other and to their counterparts without diabetes.
Materials and methods

Participants
The sample comprised of 218 respondents, 110 (50%) had diabetes -78 had GDM (36%) and 32 had type 1 diabetes mellitus (15%). The control group comprised 108 (50%) pregnant women who were unaffected by diabetes. Detailed sample characteristics are outlined in Table 1 .
Procedure
The study received ethical approval from the Institutional Research Ethics Committee and all participants provided written, informed consent. Participants were recruited from antenatal clinics at a tertiary hospital and were given an information sheet and a consent form along with an invitation to participate in the research. Those who consented were asked to complete a questionnaire pack. Maternal and neonatal characteristics and pregnancy outcomes were collected using an optimized database (Diamond, Hicom, United Kingdom).
Measures
The psychometric questionnaires are described below along with a short note about their potential relevance in understanding the responses of the participants.
(a) The Pregnancy Experience Scale (PES) 18 is a 41-item questionnaire that measures the frequency and intensity of 'hassles and uplifts' during pregnancy -a higher proportion of uplifts over hassles is reflective of a more positive pregnancy experience, and vice versa. 23 measures subjective appraisal of symptoms in terms of their perceived cause, perceived severity, likely course and consequences. Such appraisals may influence the personal response to illness. A higher score reflects a more threatening appraisal of the illness. This measure was administered to the diabetes groups only.
(f) The five-item short-form version of the Problem Areas in Diabetes Questionnaire (PAID-5) 24 measures diabetes-related distress -higher scores mean more distress and a total score of 8 indicates possible diabetes-related emotional distress which has been associated with depression and poor glycaemic control.
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The PAID-5 was administered to the diabetes groups only.
(g) Diabetes Self-Efficacy Scale (DSES) was used to measure the extent to which people with diabetes felt confident in their ability to manage their diabetes -high self-efficacy tends to be protective against emotional distress. This diabetes-specific measure was administered to the diabetes groups only.
Sample size determination
Sample size was calculated using G*Power (version 3.2) statistical power analysis software. 25 Inputting parameters including:
Mann-Whitney group comparisons as key inferential test; alpha level of 0.05, minimum power of 0.80; and a medium effect size, a required sample size of 134 was specified.
Data analysis
Data were analysed using SPSS version 21.0. Non-parametric statistics were applied in all instances, as a number of key variables were skewed and the application of logarithmic and square root transformations did not alter skewness values. Spearman's rho correlations assessed associations between key psychometric and health outcome variables (point-biserial correlation, for relationships between continuous and dichotomous variables). Mann-Whitney U tests examined differences between women with diabetes (type 1 diabetes mellitus and GDM) and those without diabetes for continuous outcomes, while Pearson chi-square tests were used for dichotomous outcomes (with post-hoc adjusted residuals to explore significant associations). Odds ratios were calculated for occurrence of clinically important levels of stress, anxiety and depression across the sample. An alpha level of P < 0.05 was used as the criterion for statistical significance.
Results
Maternal and neonatal health
There were significant differences between GDM, type 1 diabetes, and control groups on a number of health-related outcomes (see Table 1 ). In all of the following areas, there was a clear trend of worse outcomes in type 1 diabetes, followed by GDM, in comparison to controls: presence of neonatal problems and malformations; maternal hypertension; neonatal respiratory distress; and delivery type (specifically, the rate of vaginal delivery was lowest and the rate of caesarean section was highest in the diabetes groups) (all P < 0.01). Neonates delivered to women with type 1 diabetes spent more time in the neonatal intensive care unit compared with babies of women with either GDM (U ¼ 650, P ¼ 0.047) or no diabetes (U ¼ 925.5, P < 0.01).
Neonates of women with type 1 diabetes had a lower Apgar score at 5 min post-birth than the control group (U ¼ 864, P ¼ 0.02) but not the GDM group; and neonates of women with T1DM and GDM had lower birth weight (P ¼ 0.02 and P < 0.01, respectively) and height (P ¼ 0.03 and P < 0.01, respectively) than control neonates.
Depression, anxiety, stress and other psychological variables
All of the psychometric measures had acceptable reliability (see Cronbach's alpha values in Table 2 ). Mean, standard deviation, and median values for psychological variables are outlined in Table 2 . Mann-Whitney comparisons showed specific significant differences between the two diabetes groups, with women with GDM evidencing a greater number of uplifts in pregnancy (U ¼ 94, P ¼ 0.04), but also higher levels of overall general anxiety (DASS) (U ¼ 92, P ¼ 0.03) and general stress (U ¼ 82, P < 0.01). Women with GDM also had significantly elevated overall DASS depression scores, compared with the control group (U ¼ 34,
The cohort of women with type 1 diabetes had significantly lower levels of perceived social support (in particular, perceived support from friends) in contrast to the control group (U ¼ 13, P ¼ 0.04). There was also a significant difference apparent between women with GDM and type 1 diabetes for diabetes self-efficacy, with the GDM group evidencing lower self-efficacy in relation to managing their diabetes. Women with GDM had significantly higher ratings of perceived health (as evidenced by scores on the SF-8) compared with those with type 1 diabetes. For both groups of women with diabetes, the PAID questionnaire indicated that there was evidence of clinically elevated distress associated with having diabetes, although the GDM and type 1 diabetes groups did not differ significantly in that regard.
When looking at the IPQ scores, we observed an overall difference whereby women with type 1 diabetes appraised their illness as a more serious threat than the women with GDM and this was borne out when the individual questions (representing appraisals) were examined. Women with type 1 diabetes perceived their diabetes as having a bigger physical and emotional impact, more likely to be a long-term problem, a greater cause for concern in the future and a greater burden.
Recommended cut-off scores were used to establish frequency of normal, mild, moderate, severe and extremely severe depression, anxiety and stress across the three groups based on DASS scores. Chi square analyses examining differences across clinical sub-categories for the diabetic and non-diabetic groups were non-significant overall (P > 0.05 in all cases); (Table 3) . It should be noted that clinically significant emotional distress (defined as moderate or worse) was highly prevalent across all three groups -occurring in 30-60%. However, the numbers of patients in each of these subgroups was too small to enable any comparative analysis.
Correlations between maternal psychological variables and pregnancy experience
A series of correlations were performed to assess relationships between maternal anxiety, stress and depression categories, diabetes-related distress in the two diabetes samples and the experience of pregnancy.
GDM Group: In the GDM group, there was a significant positive correlation between the frequency of hassles in pregnancy and the DASS stress score (r ¼ 0.33, P ¼ 0.004) and a correlation approaching significance for the anxiety score (r ¼ 0.20, P ¼ 0.07). There was no significant correlation with the depression score. There was a significant positive correlation between the intensity of hassles in pregnancy and scores for DASS stress (r ¼ 0.35, P ¼ 0.002), anxiety (r ¼ 0.36, P ¼ 0.001) and depression (r ¼ 0.41, P ¼ 0.0001). There was a significant positive correlation between diabetes-related distress and the general DASS stress (r ¼ 0.29, P ¼ 0.01) and depression scores (r ¼ 0.30, P ¼ 0.008) but no correlation with the general anxiety score. Finally, there was a significant positive correlation between the intensity of hassles during pregnancy and the diabetes-related distress score (PAID) (r ¼ 0.25, P ¼ 0.03) and a correlation approaching significance between the intensity of pregnancy hassles and diabetesrelated distress (r ¼ 0.21, P ¼ 0.07).
Type 1 diabetes group: In the type 1 diabetes group, there was a significant positive correlation between the frequency of pregnancy hassles and DASS scores for stress (r ¼ 0.43, P ¼ 0.02) and depression (r ¼ 0.45, P ¼ 0.01) but not for anxiety. The same relationship was observed for the intensity of pregnancy hassles -correlations of 0.36 (P ¼ 0.04) and 0.53 (P ¼ 0.002) with DASS stress and depression scores, respectively. Moderate but non-significant correlations were observed between the diabetes distress score and DASS scores for stress (r ¼ 0.17), anxiety (r ¼ 0.29) and depression (r ¼ 0.33). A significant positive correlation between the intensity of pregnancy hassles and diabetesrelated distress was observed (r ¼ 0.41, P ¼ 0.02) but there was no significant correlation with the frequency of pregnancy hassles.
Control group: In the pregnant non-diabetic control group, there was a significant positive correlation between the frequency of pregnancy hassles and the general stress (r ¼ 0.33, P ¼ 0.001), anxiety (r ¼ 0.20, P ¼ 0.04) and depression scores 
Relationship between maternal psychological variables and pregnancy outcomes
A series of correlations were performed to assess relationships between anxiety, stress and depression categories and major pregnancy outcomes. There was no statistically significant association between maternal psychological variables and maternal hypertension during pregnancy, outcome of birth, preterm delivery, delivery type or infant Apgar scores.
Discussion
This study examined the psychological impact of diabetes during pregnancy by comparing pregnant women with type 1 diabetes, women with GDM, and pregnant women without diabetes. Overall, our data are consistent with previous reports that women with diabetes are more likely than those without diabetes to have medical complications during pregnancy and to experience worse outcomes such as pre-term delivery, assisted delivery and morbidities in both mother and baby. 1, 6 The highest rates of adverse clinical (medical) outcomes occurred among women with type 1 diabetes, followed by those with GDM, in comparison to women without diabetes. This phenomenon is well described and is primarily related to the degree of hyperglycaemia during pregnancy. 1, 2, 6 However, the highest rate of adverse psychological outcomes was in women with GDM, followed by women with type 1 diabetes. Our psychological data reveal that women with GDM had higher reported depression, anxiety and stress scores on average than women with type 1 diabetes, and that clinically significant levels of affective difficulties were frequently observed across all groups. Interestingly, women with type 1 diabetes had both higher selfefficacy (belief in their ability to manage their diabetes, possibly borne out of experience in self-management) but also more negative appraisals of the burden and chronicity of their diabetes, arguably reflecting a realistic understanding of their illness.
Clear correlations emerged between the perceived frequency and intensity of hassles associated with pregnancy and the psychological wellbeing scores. We had expected that women with type 1 diabetes may report higher stress and more hassles associated with pregnancy because of the long-term care needs required. However, we found that these women, despite having more medical complications, reported lower levels of psychological distress. It is possible that women with type 1 diabetes evinced lower levels of psychological stress because they had an opportunity to establish a manageable regimen of self-care before conception. In effect, they may be better adjusted to the demands of managing a chronic illness. On the other hand, women with GDM, who had comparatively fewer complications, reported higher levels of depression, stress and anxiety. This may have been associated with the burden of having been diagnosed with GDM whilst also managing the demands of pregnancy itself.
The high levels of depression and anxiety across all groups was surprising -even more so when looking at the rates with extremely severe levels of affective disturbance which ranged from 6-14% for depression symptoms and 15-32% for anxiety symptoms. Many patients with mild-to-moderate depression can be treated by psychosocial approaches including individual and group psychotherapy during pregnancy 26 as pregnant women or those preparing for conception may prefer to avoid psychoactive medication. While cognitive behavioural therapy (CBT) and interpersonal psychotherapy (IPT) have been shown to be effective for depression in pregnant women, 26 access to psychotherapy may be limited. In those cases, web and computer-based cognitive behavioural therapy are valid options.
Our findings revealed evidence of elevated diabetes-specific distress among both samples of women with diabetes. Previous research suggests that scores of 8 or higher on the PAID-5 may be clinically significant 24 -the average score for the GDM group was 8 and for the type 1 diabetes group was 9. Of relevance here is prior research demonstrating that brief psychological monitoring can effectively identify people with distress and that brief interventions can effectively manage distress. 27, 28 Prior work evaluating women with pregestational diabetes has demonstrated an association between the presence of depressive symptoms in early pregnancy and preterm delivery. We did not identify such an association and this may be related to sample size or to the fact that our sample was assessed later in pregnancy. Indeed, we did not find any strong correlations between measures of anxiety, stress or depression and clinical outcomes.
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The study had a number of limitations. Firstly, while adequately powered for correlational analyses and group comparisons, the relatively small study sample limits the study power, particularly in terms of detecting rare adverse events. Second, we relied on self-reported affective distress whereas a structured clinical interview would provide a more accurate diagnosis in terms of affective disturbance. Finally, we did not enquire about current life stressors that could provide helpful contextual information. Future research should aim to address these limitations.
In summary, we found elevated levels of depression and anxiety among a pregnant population. While women with type 1 diabetes experienced worse medical outcomes when compared to women with GDM, women with GDM experienced higher levels of depression, anxiety and stress. This work highlights a potential role for targeted psychological interventions pre-pregnancy and in early pregnancy to address and relieve these symptoms.
